Proteomic Analysis of the Dysferlin Protein Complex Unveils Its Importance for Sarcolemmal Maintenance and Integrity

Dysferlin is critical for repair of muscle membranes after damage. Mutations in dysferlin lead to a progressive muscular dystrophy. Recent studies suggest additional roles for dysferlin. We set out to study dysferlin's protein-protein interactions to obtain comprehensive knowledge of dysferlin functionalities in a myogenic context. We developed a robust and reproducible method to isolate dysferlin protein complexes from cells and tissue. We analyzed the composition of these complexes in cultured myoblasts, myotubes and skeletal muscle tissue by mass spectrometry and subsequently inferred potential protein functions through bioinformatics analyses. Our data confirm previously reported interactions and support a function for dysferlin as a vesicle trafficking protein. In addition novel potential functionalities were uncovered, including phagocytosis and focal adhesion. Our data reveal that the dysferlin protein complex has a dynamic composition as a function of myogenic differentiation. We provide additional experimental evidence and show dysferlin localization to, and interaction with the focal adhesion protein vinculin at the sarcolemma. Finally, our studies reveal evidence for cross-talk between dysferlin and its protein family member myoferlin. Together our analyses show that dysferlin is not only a membrane repair protein but also important for muscle membrane maintenance and integrity.

[1]  C. Paradas,et al.  Dysferlin expression in monocytes: A source of mRNA for mutation analysis , 2007, Neuromuscular Disorders.

[2]  C. Keller,et al.  Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion. , 2009, Molecular biology of the cell.

[3]  Thomas A Rando,et al.  Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells. , 2006, Developmental biology.

[4]  Xavier Collet,et al.  Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis , 2003, Nature.

[5]  M. Sinnreich,et al.  Dysferlin Interacts with Tubulin and Microtubules in Mouse Skeletal Muscle , 2010, PloS one.

[6]  K. Bushby,et al.  Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display , 2005, European Journal of Human Genetics.

[7]  Martijn J. Schuemie,et al.  Literature-based concept profiles for gene annotation: The issue of weighting , 2008, Int. J. Medical Informatics.

[8]  K. Miyake,et al.  Calpain Is Required for the Rapid, Calcium-dependent Repair of Wounded Plasma Membrane* , 2007, Journal of Biological Chemistry.

[9]  Johan T den Dunnen,et al.  Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. , 2008, Human molecular genetics.

[10]  M. Keating,et al.  Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy , 2002, Circulation.

[11]  S. Takeda,et al.  Intracellular localization of dysferlin and its association with the dihydropyridine receptor. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[12]  S. Takeda,et al.  Identification and characterization of a novel human dysferlin transcript: dysferlin_v1 , 2006, Human Genetics.

[13]  K. Kameyama,et al.  Dysferlin interacts with affixin (beta-parvin) at the sarcolemma. , 2005, Journal of neuropathology and experimental neurology.

[14]  K. Bushby,et al.  Diagnosis and management of the limb girdle muscular dystrophies , 2009, Practical Neurology.

[15]  M. Sinnreich,et al.  Characterization of lipid binding specificities of dysferlin C2 domains reveals novel interactions with phosphoinositides. , 2009, Biochemistry.

[16]  I. Illa,et al.  A novel, blood‐based diagnostic assay for limb girdle muscular dystrophy 2B and miyoshi myopathy , 2002, Annals of neurology.

[17]  M. Mann,et al.  Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.

[18]  Y. Kalaidzidis,et al.  Systems survey of endocytosis by multiparametric image analysis , 2010, Nature.

[19]  Y. Hayashi,et al.  Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II). , 2007, Human molecular genetics.

[20]  M. Ubbink,et al.  Structural basis for a PABPN1 aggregation‐preventing antibody fragment in OPMD , 2010, FEBS letters.

[21]  P. Krajacic,et al.  C. elegans dysferlin homolog fer-1 is expressed in muscle, and fer-1 mutations initiate altered gene expression of muscle enriched genes. , 2009, Physiological genomics.

[22]  K. Bushby,et al.  Characterisation of the dysferlin skeletal muscle promoter , 2004, European Journal of Human Genetics.

[23]  J. Beckmann,et al.  Calpain 3, the “gatekeeper” of proper sarcomere assembly, turnover and maintenance , 2008, Neuromuscular Disorders.

[24]  I. Illa,et al.  Role of Thrombospondin 1 in Macrophage Inflammation in Dysferlin Myopathy , 2010, Journal of neuropathology and experimental neurology.

[25]  Chien-Chang Chen,et al.  Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.

[26]  K. Bushby,et al.  Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy , 2009, Human molecular genetics.

[27]  P. Avan,et al.  Otoferlin, Defective in a Human Deafness Form, Is Essential for Exocytosis at the Auditory Ribbon Synapse , 2006, Cell.

[28]  T. Rando,et al.  Integrin-mediated Muscle Cell Spreading , 1999, The Journal of Biological Chemistry.

[29]  E. Hoffman,et al.  Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. , 2008, The American journal of pathology.

[30]  M. Nishi,et al.  MG53 nucleates assembly of cell membrane repair machinery , 2009, Nature Cell Biology.

[31]  M. Noble,et al.  Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. , 1994, Developmental biology.

[32]  F. Luft.  Dysferlin, dystrophy, and dilatative cardiomyopathy , 2007, Journal of Molecular Medicine.

[33]  M. Cohen-Salmon,et al.  A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness , 1999, Nature Genetics.

[34]  M. Baiget,et al.  Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype , 2001, Annals of neurology.

[35]  J. Hancock,et al.  Caveolin Regulates Endocytosis of the Muscle Repair Protein, Dysferlin* , 2008, Journal of Biological Chemistry.

[36]  J. Pouget,et al.  Immunolabelling and flow cytometry as new tools to explore dysferlinopathies , 2010, Neuromuscular Disorders.

[37]  J. T. Dunnen,et al.  AHNAK a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  K. Bushby,et al.  Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. , 2006, Human molecular genetics.

[39]  K. Kameyama,et al.  Dysferlin Interacts with Affixin (β-Parvin) at the Sarcolemma , 2005 .

[40]  Pieter J. de Jong,et al.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy , 1998, Nature Genetics.

[41]  K. Kameyama,et al.  Affixin activates Rac1 via βPIX in C2C12 myoblast , 2008, FEBS letters.

[42]  I. Nonaka,et al.  The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. , 2001, Human molecular genetics.

[43]  Y. Sunada,et al.  Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin*◆ , 2009, The Journal of Biological Chemistry.

[44]  D. Davis,et al.  Normal myoblast fusion requires myoferlin , 2005, Development.

[45]  J. Beckmann,et al.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.

[46]  K. Bushby,et al.  From T‐tubule to sarcolemma: damage‐induced dysferlin translocation in early myogenesis , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  D. Davis,et al.  Myoferlin, a candidate gene and potential modifier of muscular dystrophy. , 2000, Human molecular genetics.

[48]  P. Robinson,et al.  Novel sequence variants in dysferlin‐deficient muscular dystrophy leading to mRNA decay and possible C2‐domain misfolding , 2006, Human mutation.

[49]  Steven S. Vogel,et al.  Membrane wounding triggers ATP release and dysferlin-mediated intercellular calcium signaling , 2010, Journal of Cell Science.

[50]  A. Suzuki,et al.  Affixin interacts with α-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell–substrate interaction , 2004, The Journal of cell biology.

[51]  K. Bushby,et al.  Dysferlin is a plasma membrane protein and is expressed early in human development. , 1999, Human molecular genetics.

[52]  J. Meldolesi,et al.  Regulated exocytosis: a novel, widely expressed system , 2002, Nature Cell Biology.

[53]  J. Meldolesi,et al.  Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis , 2006, The EMBO journal.

[54]  M. Frosch,et al.  Differential recognition of vascular and parenchymal beta amyloid deposition , 2011, Neurobiology of Aging.

[55]  J. Watson,et al.  Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b. , 2008, Journal of molecular biology.

[56]  B. Hyman,et al.  Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing* , 2003, Journal of Biological Chemistry.

[57]  N. Romero,et al.  Loss of podocyte dysferlin expression is associated with minimal change nephropathy. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  N. Bourg,et al.  Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases. , 2009, Biochimica et biophysica acta.

[59]  S. Ward,et al.  FER-1 regulates Ca2+-mediated membrane fusion during C. elegans spermatogenesis , 2006, Journal of Cell Science.

[60]  R. Lovering,et al.  Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo , 2008, Neuroreport.

[61]  M. Palacín,et al.  Isolation and characterization of distinct domains of sarcolemma and T-tubules from rat skeletal muscle. , 1995, The Biochemical journal.

[62]  P. Mcneil,et al.  Requirement for Annexin A1 in Plasma Membrane Repair* , 2006, Journal of Biological Chemistry.

[63]  C. Petit,et al.  OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9. , 2000, American journal of human genetics.

[64]  E. Hoffman,et al.  Mutations in the integrin alpha7 gene cause congenital myopathy. , 1998, Nature genetics.

[65]  J. Meldolesi,et al.  Enlargeosome Traffic: Exocytosis Triggered by Various Signals Is Followed by Endocytosis, Membrane Shedding or Both , 2007, Traffic.